OptimizeRx Enables DSPs to Tap 90% U.S. Digital Display Ad Spend

OPRXOPRX

OptimizeRx launched a programmatic connection between its proprietary EHR network and DSPs, enabling media buyers to integrate point-of-care campaigns directly into existing workflows. The move opens access to an estimated 90% of U.S. digital display ad spend and the $19 billion pharma digital advertising market.

1. Programmatic EHR Integration

OptimizeRx launched a new programmatic connection enabling DSPs to integrate directly with its proprietary EHR network, allowing media buyers to activate authenticated point-of-care campaigns within existing workflows.

2. Tapping Major Digital Ad Market

This integration opens access to an estimated 90% of total U.S. digital display ad spend across industries and targets the $19 billion pharmaceutical digital advertising market.

3. Benefits for Buyers and DSPs

Media buyers can self-manage reach, frequency and scale of EHR placements while DSPs gain a bot-free, premium point-of-care inventory for life sciences clients, enhancing omnichannel strategies and competitive differentiation.

Sources

F